Effect of Homoeopathic Medicine Gnaphalium in the Treatment of Lowback pain extending to leg
Phase 4
- Conditions
- Health Condition 1: M544- Lumbago with sciaticaHealth Condition 2: M543- Sciatica
- Registration Number
- CTRI/2023/10/059226
- Lead Sponsor
- Vinayaka Missions Homoeopathic Medical College and Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Sciatica Patients (ICD 11 - ME84.3)
Exclusion Criteria
Degenerative conditions of spine - Vertebral osteochondrosis, Spondylosis, Facet joints, Spondylolysis & spondylolisthesis, Degenerative stenosis, Known Lesions of sciatic nerve Chronic neuropathic pain by any Specific Diseases
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the efficacy of Gnaphalium polycephalum.Q in treating sciatica (M544, M543)?
How does Gnaphalium polycephalum.Q compare to NSAIDs or corticosteroids in managing low back pain with sciatica?
What are the key findings from the CTRI/2023/10/059226 trial on Gnaphalium polycephalum.Q for sciatica (M544, M543)?
Are there biomarkers that predict response to Gnaphalium polycephalum.Q in patients with lumbago-sciatica (M544)?
What combination therapies or related compounds enhance Gnaphalium polycephalum.Q's efficacy in treating M543 sciatica?